Cronos had a drop in third-quarter profit due to a rise in operating expenses and income tax provision, and despite increased revenue with record sales in Canada, Germany and for an 11th consecutive quarter in Israel.
The Canadian cannabis company said its net income for the three months fell to $17.8 million, or 4 cents a share, from $28.3 million, or 7 cents a share, a year earlier.
Earnings before interest, taxes, depreciation and amortization on an adjusted basis climbed to $17.1 million from $5.68 million in 2025.
Revenue increased 75% on last year to $63.5 million . The cost of sales for the period was up 69%, and Cronos booked an inventory writedown of $1.64 million, more than three times the level a year prior.
Cronos, whose brands include Spinach, Peace Naturals and Lord Jones, said its Spinach in Canada brand continued to gain market share and maintained its top position in vapes for a third straight quarter and leading position in edibles for the ninth consecutive quarter. Peace Naturals continues to be the leading cannabis brand in Israel, it said.
Canadian medical-cannabis Aurora Cannabis grew its revenue 9.2% in the latest quarter to 86 million Canadian dollars ($62 million), buoyed by a 44% rise in international medical cannabis to a record C$61.4 million.
That helped drive Aurora to a narrower third-quarter loss of C$21.1 million, from C$53 million a year earlier. The result last year for continuing operations was weighed down by C$13.7 million in impairment charges.
On an adjusted basis, Aurora's earnings before interest, taxes, depreciation and amortization came in at C$14 million against last year's C$15.4 million.
Aurora this week agree to be bought by Canada's Organigram Global for roughly C$560 million, allowing it to fend off a hostile bid from U.S. weed chain Curaleaf Holdings.
Comments